APS Logo   AGA Logo                                                FAll Meeting

American Psychosomatic Society - American Gastroenterological Association Symposium on Brain-Gut Interactions and the Intestinal Microenvironment

New York Marriott Downtown, New York, NY - September 25, 2015

"The impact of the microbiome on health and disease, from microbiology through psychosocial processes."

This meeting will feature presentations in basic, animal, translational and clinical aspects of brain-gut communication as it relates to nutrition, the gut microbiome and human emotion and behavior in health and disease. Featuring renowned experts in the field, this full day Symposium will highlight mechanistic biopsychosocial research relating to Brain-Gut Interactions. A significant portion of the meeting will be devoted to discussion and information sharing between the presenters and the audience, and through this interaction, the meeting will further help to translate research to clinical applications.


Preliminary Schedule


7:30 - 8:30 am




8:30 - 8:40 am

Welcome and Introduction
Moderators - Douglas A. Drossman, MD and Magnus Simren, MD, PhD


8:40 - 10:00 am

Session 1: Gut microbiota: The basics
Defining the Gut Microbiota - Erwin Zoetendal, PhD
The importance of the Gut Microbiome in Health and Disease - Gary Wu, MD
Methods to determine the composition and function of the gut microbiota - Erwin Zoetendal, PhD

Discussion with the Audience




10:00 - 10:30 am

AM Break



10:30 - 11:50 am

Session 2: Gut microbiota and neural systems: physiology and pathophysiology
Interaction between intestinal microbiota, GI immune and barrier function, and the enteric nervous system - Stephen M. Collins MBBS, FRCPC, FRSC
The effect of external stressors on gut microbiota composition and function - Michael T. Bailey, PhD
Gut microbes and the brain: paradigm shift in neuroscience - Emeran Mayer, MD
Discussion with the Audience




12:00 - 1:00 pm



1:00 - 3:00 pm

Session 3: The Role of Microbiota in medical and neuropsychiatric diseases
Understanding the microbiota in neurological diseases - Lloyd H Kasper, MD
Understanding the microbiota in psychiatric diseases - Timothy G Dinan, MD, PhD
Understanding the microbiota in GI disease (IBD, IBS) - Magnus Simren, MD, PhD
Understanding the microbiota in metabolic conditions (Non-alcoholic fatty liver disease, Cardiovascular disease, Metabolic syndrome) - Max Nieuwdorp, MD, PhD
Discussion with the Audience



3:00 - 3:30 pm

PM Break


3:30 - 4:50 pm

Session 4: Manipulating the gut microbiome as a treatment strategy
Diet - Shanti Eswaran, MD
Pre-, pro-, and antibiotics - Eamonn Quigley, MD
Fecal microbial transplantation - Lawrence J Brandt, MD
Discussion with the Audience




5:00 - 6:15 pm

Q&A / Reception



A special half day workshop for those with particular interest will be held the day following the Symposium to develop a set of concepts and recommendations leading to a future research agenda. The information gleaned from the Symposium and the recommendations that develop from the workshop forum will be an important component that will help direct future research and practical applications in this emerging field. There is no additional charge for attending this session, however space is limited and your attendance at Saturday's program is not guaranteed until you have received an email from APS confirming your participation. See the registration form for details. CME credit will be available for the Symposium.

New York Marriott Downtown

Hotel Information

New York Marriott Downtown
85 West Street at Albany Street
New York, NY 10006 USA

For room reservations, call 877-303-0104 and inform them that you are attending the American Psychosomatic Society meeting. You can also book your reservation online

The American Psychosomatic Society has arranged for a block of sleeping rooms at the New York Marriott Downtown, with a special starting rate of $269 plus applicable state and local taxes. These rooms will be available until the block of rooms is filled, or August 27, 2015, whichever comes first - - please make your reservation early to ensure that there is space available. Group rates are available between September 24, 2015 - September 27, 2015.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Advancement of Human Behavior (IAHB) and the American Psychosomatic Society (APS). The IAHB is accredited by the ACCME to provide continuing medical education for physicians.

The IAHB designates this live activity for a maximum of 7.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

A very special Thank You to our sponsors and supporters


Actavis + Allergan

Allergan (NYSE: AGN) is a unique, global pharmaceutical company focused on developing, manufacturing and commercializing high quality generic and innovative branded pharmaceutical products for patients around the world.  The Company has approximately 30,000 employees worldwide and maintains global headquarters in Dublin, Ireland. For more information, visit www.Allergan.com.

Ironwood Pharmaceuticals (NASDAQ: IRWD) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholders, and empowering our team to passionately pursue excellence. We discovered, developed and are commercializing linaclotide, which is approved in the United States, the European Union, and a number of other countries. Our pipeline priorities include exploring further opportunities for linaclotide, as well as leveraging our therapeutic expertise in gastrointestinal disorders and our pharmacologic expertise in guanylate cyclases to address patient needs across the upper and lower gastrointestinal tract. Ironwood was founded in 1998 and is headquartered in Cambridge, Mass. Connect with us at www.ironwoodpharma.com or on Twitter at www.twitter.com/ironwoodpharma; information that may be important to investors will be routinely posted in both these locations.



R&D is at the very heart of Danone’s mission: “bringing health through food to as many people as possible”. Danone Nutricia Research combines the research and innovation of Danone, through 1500 researchers and developers all around the world, gathered in 6 research centers and 55 R&D branches. Danone Nutricia Research favors healthier eating and drinking practices and delivers safe, healthy and enjoyable food products firmly rooted in scientific and technological knowledge. http://www.danone.com/en/



Rome Foundation
The Rome Foundation provides support for activities designed to create scientific data and educational information to assist in the diagnosis and treatment of functional gastrointestinal disorders (FGIDs). Over the last 19 years, the Rome organization has sought to legitimize and update our knowledge of the FGIDs by bringing together scientists and clinicians from around the world to classify and critically appraise the science of gastrointestinal function and dysfunction. This knowledge permits clinical scientists to make recommendations for diagnosis and treatment that can be applied in research and clinical practice.



American Gastroenterological Association Institute
The American Gastroenterological Association (AGA) is the trusted voice of the GI community. The AGA administers all membership and public policy activities, while the AGA Institute, a 501(c)(3) organization, runs the organization’s practice, research and educational programs. On a monthly basis, the AGA Institute publishes two highly respected journals,  Gastroenterology and Clinical Gastroenterology and Hepatology. The organization's annual meeting is  Digestive Disease Week®, which is held each May and is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.